[{"Assets_0_Q3_USD":456775000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":40828000.0,"NetIncomeLoss_1_Q3_USD":3895000.0,"NetIncomeLoss_3_Q3_USD":10929000.0,"StockholdersEquity_0_Q3_USD":213130000.0,"EarningsPerShareBasic_1_Q3_USD":0.32,"EarningsPerShareBasic_3_Q3_USD":0.91,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":11879000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":11826000.0,"Ticker":"ANIP","CIK":"1023024","name":"ANI PHARMACEUTICALS INC","OfficialName":"ANI Pharmaceuticals Inc.","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"569805985.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20191106"}]